Clinical Trials Browser

Active not recruiting × bemarituzumab × 1 year × Clear all

NCT05052801 2026-02-19

FORTITUDE-101

Phase 3 Active not recruiting

Gastrointestinal

Stomach Neoplasms

NCT05111626 2025-12-15

FORTITUDE-102

Phase 3 Active not recruiting

Gastrointestinal

Stomach Neoplasms

NCT05322577 2025-12-05

FORTITUDE-103

Phase 1/2 Active not recruiting

Gastrointestinal

Stomach Neoplasms